in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
U.K. Pseudoephedrine Curb?
11:18 AM MDT | July 27, 2007 | Chemical Week Editorial Staff
U.K. government agency the Medicines and Healthcare Products Regulatory Agency (MHRA) has proposed a reclassification of medicines containing pseudoephedrine and ephedrine as prescription-only drugs. The substances are often used in over-the-counter cold and flu treatments. The reclassification could hurt manufacturers of pseudoephedrine and ephedrine, because pharmaceutical companies may respond to the changes by formulating new medicines that omit the two products. BASF has slashed jobs and reduced psuedoephedrine production at Minden, Germany during the past...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee